Try our Advanced Search for more refined results

In Re: Actos (Pioglitazone) Products Liability Litigation

  1. June 12, 2014

    Eli Lilly Ducks Perjury Sanctions In $9B Actos Case

    A federal judge on Wednesday declined to sanction Eli Lilly & Co. or subject a former executive to criminal investigation for zig-zagging on the stand during a bellwether trial alleging the diabetes drug Actos caused bladder cancer, saying the questionable testimony hadn't stopped the plaintiffs from winning a $9 billion verdict.

  2. April 24, 2014

    Takeda Won't Commit To Cover Eli Lilly For $9B Verdict

    Takeda Pharmaceutical Co. Ltd. isn't conceding that it needs to pay Eli Lilly & Co.'s piece of a $9 billion verdict against the two companies for allegedly hiding the cancer risks of the diabetes drug Actos, the Japan-based drugmaker said Thursday.

  3. April 08, 2014

    $9B Verdict Hammers Takeda, Eli Lilly In Actos Bellwether

    A Louisiana federal jury on Monday ordered Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. to pay more than $9 billion in damages to a couple, in a bellwether trial over allegations the companies hid the cancer risks of diabetes drug Actos to keep sales high.

  4. March 18, 2014

    Eli Lilly Slams Bid To Dredge Up Zyprexa Past In Actos Row

    Eli Lilly & Co. argued in Louisiana district court Monday that the Actos bellwether trial plaintiffs are seeking extreme sanctions over a former executive's testimony on a different drug — one which the drugmaker copped to a criminal charge for in 2009 — simply to tarnish its image with the jury.

  5. January 29, 2014

    Possible Sanctions For Takeda In Actos Bladder Cancer MDL

    A Louisiana federal judge has found that Takeda Pharmaceuticals America Inc. breached a duty to preserve evidence in multidistrict litigation claiming its anti-diabetic drug Actos causes bladder cancer, saying she would decide what sanctions are warranted during a bellwether trial starting Monday.

  6. June 03, 2013

    Takeda, Eli Lilly Want Ark. Taxpayer's Actos Suit Nixed

    Takeda Pharmaceuticals Co. Ltd. and Eli Lilly & Co. urged a Louisiana federal judge on Friday to dismiss a class action alleging they ripped off taxpayers by hiding the risks of their diabetes drug Actos, saying the plaintiff hadn't properly pled violations of an Arkansas constitutional prohibition on misuse of public funds.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!